+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

Cyclophosphamide Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cyclophosphamide Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
From
From
Antibiotic Resistance Market Report 2025 - Product Thumbnail Image

Antibiotic Resistance Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Glycopeptide Antibiotics Market Report 2025 - Product Thumbnail Image

Glycopeptide Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Peptide Antibiotics Market Report 2025 - Product Thumbnail Image

Peptide Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
Cell Wall Synthesis Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Cell Wall Synthesis Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 90 Pages
  • Global
From
Loading Indicator